Sylvain Chemtob Selected Research

Small Interfering RNA (siRNA)

1/2021	Tyrosine-Protein Phosphatase Non-receptor Type 9 (PTPN9) Negatively Regulates the Paracrine Vasoprotective Activity of Bone-Marrow Derived Pro-angiogenic Cells: Impact on Vascular Degeneration in Oxygen-Induced Retinopathy.
3/2009	The role of lysophosphatidic acid receptor (LPA1) in the oxygen-induced retinal ganglion cell degeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sylvain Chemtob Research Topics

Disease

37	Inflammation (Inflammations) 06/2024 - 02/2003
19	Premature Birth (Birth, Premature) 11/2023 - 07/2015
16	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2021 - 07/2002
15	Hyperoxia 08/2023 - 07/2002
9	Premature Obstetric Labor (Premature Labor) 01/2023 - 12/2002
8	Ischemia 01/2022 - 02/2006
8	Hypercapnia 06/2010 - 05/2002
7	Hypoxia (Hypoxemia) 12/2016 - 03/2009
7	Retinal Neovascularization 01/2016 - 04/2006
6	Choroidal Neovascularization 11/2019 - 05/2011
5	Pathologic Neovascularization 01/2022 - 07/2011
5	Retinal Degeneration 11/2020 - 10/2007
5	Neoplasms (Cancer) 01/2019 - 10/2003
4	Brain Injuries (Brain Injury) 10/2023 - 10/2008
4	Macular Degeneration (Age-Related Maculopathy) 01/2019 - 10/2007
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2016 - 05/2008
3	Neuroinflammatory Diseases 11/2023 - 04/2021
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 01/2005
3	Infections 01/2020 - 10/2015
3	Platelet Glycoprotein IV Deficiency 01/2019 - 02/2008
2	COVID-19 04/2024 - 01/2020
2	Chorioamnionitis 11/2023 - 01/2021
2	Infarction (Infarctions) 01/2022 - 02/2014
2	Pregnancy Complications 12/2020 - 12/2016
2	Blindness (Hysterical Blindness) 01/2020 - 12/2016
2	Rheumatoid Arthritis 01/2019 - 11/2014
2	Triple Negative Breast Neoplasms 01/2019 - 02/2018
2	Atrophy 01/2017 - 02/2008
2	Wounds and Injuries (Trauma) 01/2017 - 08/2004
2	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2016 - 11/2014
2	Ganglion Cysts (Ganglion) 08/2013 - 10/2008
2	Corneal Neovascularization 03/2012 - 05/2009
2	Patent Ductus Arteriosus 06/2011 - 10/2004
2	Hepatocellular Carcinoma (Hepatoma) 06/2006 - 10/2003
2	Retinal Vein Occlusion 05/2005 - 01/2005
2	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 04/2003 - 03/2003
1	Weight Loss (Weight Reduction) 04/2024
1	Acute Lung Injury 04/2024
1	Lung Injury 04/2024
1	Encephalitis (Encephalitis, Rasmussen) 11/2023
1	Eye Diseases (Eye Disease) 01/2022

Drug/Important Bio-Agent (IBA)

39	Retinaldehyde (Retinal)IBA 08/2023 - 05/2002
16	Oxygen (Dioxygen)IBA 12/2020 - 07/2002
12	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2023 - 10/2008
10	Interleukin-1 (Interleukin 1)IBA 04/2024 - 10/2008
8	LipopolysaccharidesIBA 11/2023 - 08/2010
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2023 - 02/2008
7	CytokinesIBA 11/2023 - 04/2016
7	ProstaglandinsIBA 03/2023 - 05/2002
6	Tocolytic Agents (Tocolytics)IBA 06/2024 - 09/2011
6	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 04/2024 - 10/2008
6	InterleukinsIBA 04/2024 - 04/2016
6	101.10 peptideIBA 11/2023 - 10/2008
6	Peptides (Polypeptides)IBA 08/2023 - 10/2008
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2002
6	LipidsIBA 01/2022 - 08/2002
5	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019 - 05/2013
5	Succinic Acid (Succinate)IBA 02/2014 - 10/2008
4	LigandsIBA 01/2019 - 10/2006
4	lysophosphatidic acidIBA 03/2009 - 10/2003
4	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 11/2007 - 05/2002
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 01/2017
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2017
3	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2019
3	Scavenger Receptors (Scavenger Receptor)IBA 01/2019 - 02/2008
3	Interleukin-12 (IL 12)IBA 01/2019 - 01/2014
3	Interleukin-23 (Interleukin 23)IBA 04/2016 - 01/2014
3	Semaphorin-3AIBA 02/2015 - 08/2012
3	oxidized low density lipoproteinIBA 06/2013 - 10/2006
2	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2024 - 01/2019
2	ChemokinesIBA 06/2024 - 11/2023
2	EnzymesIBA 11/2023 - 05/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2023 - 09/2013
2	Small Interfering RNA (siRNA)IBA 01/2021 - 03/2009
2	KininsIBA 09/2020 - 01/2019
2	Amino Acids FDA Link 01/2019 - 09/2011
2	Interleukin-10 (Interleukin 10)IBA 01/2019 - 01/2017
2	A-factor (Streptomyces)IBA 11/2017 - 09/2017
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2017 - 12/2002
2	EndotoxinsIBA 01/2017 - 12/2002
2	platelet activating factor receptorIBA 01/2016 - 01/2016
2	Semaphorins (Semaphorin)IBA 08/2012 - 01/2011
2	GS 101IBA 03/2012 - 05/2009
2	Arachidonic AcidsIBA 01/2011 - 02/2010
2	DinoprostIBA 08/2010 - 03/2003
2	Arachidonic Acid (Vitamin F)IBA 11/2007 - 06/2006
2	Platelet Activating FactorIBA 03/2006 - 01/2005
2	Dinoprostone (PGE2)FDA Link 02/2006 - 10/2004
2	Oxidants (Oxidizing Agents)IBA 08/2004 - 04/2003
1	Interleukin Receptors (Interleukin Receptor)IBA 06/2024
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 04/2024
1	Bleomycin (Blenoxane)FDA LinkGeneric 04/2024
1	tocilizumab (atlizumab)FDA Link 04/2024
1	erucylphosphocholineIBA 08/2023
1	NF-kappa B (NF-kB)IBA 01/2023
1	Mitogen-Activated Protein KinasesIBA 01/2023

Therapy/Procedure

10	Therapeutics 06/2024 - 03/2012
4	Lasers (Laser) 11/2016 - 10/2007
3	Injections 11/2023 - 03/2006
2	Intraperitoneal Injections 08/2023 - 12/2013